AW
LGND icon

Avion Wealth’s Ligand Pharmaceuticals LGND Stock Holding History

Avion Wealth’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1K Hold
9
– – ﹤0.01% 1078
2025
Q4 		$1K Hold
9
– – ﹤0.01% 1070
2025
Q3 		$1K Hold
9
– – ﹤0.01% 1041
2025
Q2 		$1K Hold
9
– – ﹤0.01% 1000
2025
Q1 		$0 Buy
+9
New +$1.02K ﹤0.01% 1216
2024
Q4 		– Sell
-9
Closed – – 1165
2024
Q3 		$0 Hold
9
– – ﹤0.01% 1197
2024
Q2 		$0 Hold
9
– – ﹤0.01% 1120
2024
Q1 		$1K Hold
9
– – ﹤0.01% 993
2023
Q4 		$1K Buy
+9
New +$531 ﹤0.01% 856

Other funds holding LGND

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return

Avion Wealth's LGND Position: Q1 2026 in Review

Avion Wealth held its Ligand Pharmaceuticals (LGND) position steady in Q1 2026 at 9 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #1078.

Avion Wealth first reported a position in LGND in Q4 2023 and has held it in 9 quarters since. 357 funds tracked by Wall St. Rank hold LGND as of Q1 2026.

  • Avion Wealth held 9 shares of Ligand Pharmaceuticals worth $1K as of Q1 2026.
  • Avion Wealth left its Ligand Pharmaceuticals share count unchanged in Q1 2026.
  • Ligand Pharmaceuticals made up ﹤0.01% of Avion Wealth's portfolio in Q1 2026, its #1078 holding.
  • Avion Wealth first reported a position in Ligand Pharmaceuticals in Q4 2023 and has held it in 9 quarters since.
  • 357 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q1 2026.

Based on Avion Wealth's 13F filing for Q1 2026, filed 1 May 2026.